Skip to main content

The Role of the Endothelium in the Cardiovascular Response to Serotonin

  • Chapter
Serotonin

Abstract

Serotonin causes constriction of the vascular smooth muscle cells and platelet aggregation mainly through activation of 5-HT2-serotonergic receptors. The vasoconstrictor effects of serotonin can be counteracted by the prejunctional inhibition of adrenergic neurotransmission and predominantly by the release of endothelium derived relaxing factor. These effects of the monoamine are caused by activation of 5-HT1-like serotonergic receptors. Endothelium derived relaxing factor also prevents platelet aggregation and adhesion to the vascular wall. When the endothelium is dysfunctional, as is the case in atherosclerosis or after the endothelium has recovered from an injury, serotonin cannot induce the liberation of endothelium derived relaxing factor but will cause the release of endothelium derived contracting factor. As a result platelet aggregation and vasoconstriction can occur. Serotonin may also increase the viscosity of the blood by an action on red and white blood cells, which may cause a further impairment of blood flow. At the same time platelet derived growth factor, released from aggregating blood platelets may cause proliferation of the vascular smooth muscle cells which participates in the progression of atherosclerosis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Alheid, U., Frölich, J. C. and Förstermann, U. (1987) ‘Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets’, Thromb. Res. 47, 561–571.

    Article  PubMed  CAS  Google Scholar 

  • Azuma, H., Ishikawa, M. and Sekizaki, S. (1986) ‘Endothelium-dependent inhibition of platelet aggregation’, Br. J. Pharmacol. 88, 411–415.

    PubMed  CAS  Google Scholar 

  • Bevan, J. A. and Heptinstall, S. (1983) ‘Effects of ketanserin and mepyramine on platelet aggregation and on the uptake of 5-hydroxytryptamine into platelets’, Thromb. Res. 30, 415–423.

    Article  PubMed  CAS  Google Scholar 

  • Bogar, L., Matrai, A., Walker, R. T., Flute, P. T. and Dormandy, J. A. (1985) ‘Haemorheological effects of a 5-HT2-receptor antagonist (ketanserin)’, Clin. Haemorheol. 5, 115–121.

    Google Scholar 

  • Bult, H., Fret, H. R. L., Van den Bossche, R. M. and Herman, A. G. (1988) ‘Platelet inhibition by endothelium-derived relaxing factor from the rabbit perfused aorta’, Br. J. Pharmacol. 95, 1308–1314.

    PubMed  CAS  Google Scholar 

  • Bush, L. R., Campbell, W. B., Kern, K., Tilton, G. D., Apprill, P., Ashton, J., Schmitz, J., Buja, L. M. and Willerson, J. T. (1984) ‘The effects of alpha2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries’, Circ. Res. 55, 642–652.

    PubMed  CAS  Google Scholar 

  • Cocks, T. M. and Angus, J. A. (1983) ‘Endothelium-dependent relaxation of coronary arteries by noradrenaline and serotonin’, Nature (Lond.) 305, 627–630.

    Article  CAS  Google Scholar 

  • Cohen, M. L., Fuller, R. W. and Wiley, K. S. (1981) ‘Evidence for 5-HT2 receptors mediating contraction in vascular smooth muscle’, J. Pharmacol. Exp. Ther. 218, 421–425.

    PubMed  CAS  Google Scholar 

  • Cohen, R. A. (1985a) ‘Platelet-induced neurogenic coronary contractions due to accumulation of the false neurotransmitter, 5-hydroxytryptamine’, J. Clin. Invest. 75, 286–292.

    Article  PubMed  CAS  Google Scholar 

  • Cohen, R. A. (1985b) ‘Serotonergic prejunctional inhibition of canine coronary adrenergic nerves’, J. Pharmacol. Exp. Ther. 235, 76–80.

    PubMed  CAS  Google Scholar 

  • Cohen, R. A. (1987) ‘Inhibition of adrenergic neurotransmission in canine tibial artery after exposure to 5-hydroxytryptamine in vitro’ J. Pharmacol. Exp. Ther. 242, 493–498.

    Google Scholar 

  • Cohen, R. A., Shepherd, J. T. and Vanhoutte, P. M. (1983a) ‘5-Hydroxytryptamine can mediate endothelium-dependent relaxation of coronary arteries’, Am. J. Physiol. 245, H1077–H1080.

    PubMed  CAS  Google Scholar 

  • Cohen, R. A., Shepherd, J. T. and Vanhoutte, P. M. (1983b) ‘Inhibitory role of the endothelium in the response of isolated coronary arteries to platelets’, Science 221, 273–274.

    Article  PubMed  CAS  Google Scholar 

  • Cohen, R. A., Shepherd, J. T. and Vanhoutte, P. M. (1984) ‘Endothelium and asymmetrical responses of the coronary arterial wall’, Am. J. Physiol. 247, H403–H408.

    PubMed  CAS  Google Scholar 

  • Cohen, R. A., Zitnay, K. M. and Weisbrod, R. M. (1987) ‘Accumulation of 5-hydroxytryptamine leads to dysfunction of adrenergic nerves in canine coronary artery following intimal damage in vivo’, Circ. Res. 61, 829–833.

    PubMed  CAS  Google Scholar 

  • Collis, M. G. and Vanhoutte, P. M. (1977) ‘Vascular reactivity of isolated perfused kidneys from male and female spontaneously hypertensive rats’, Circ. Res. 41, 759–767.

    PubMed  CAS  Google Scholar 

  • de Chaffoy de Courcelles, D., Roevens, P., Van Belle, H. and De Clerck, F. (1987) ‘The synergistic effect of serotonin and epinephrine on the human platelet at the level of signal transduction’, FEBS Lett. 219, 283–288.

    Google Scholar 

  • De Clerck, F., David, J. L. and Janssen, P. A. J. (1982) ‘Inhibition of 5-hydroxytryptamine-induced and amplified human platelet aggregation by ketanserin (R 41 468), a selective 5-HT 2 receptor antagonist’, Agents Actions 12, 388–397.

    Article  PubMed  Google Scholar 

  • De Clerck, F. and Herman, A. G. (1983) ‘5-Hydroxytryptamine and platelet aggregation’, Fed. Proc. 42, 228–232.

    PubMed  Google Scholar 

  • De Clerck, F. and Van Nueten, J. M. (1982) ‘Platelet-mediated vascular contractions: Inhibition of the serotonergic component by ketanserin’, Thromb. Res. 27, 713–727.

    Article  PubMed  Google Scholar 

  • De Clerck, F., Van Nueten, J. M. and Reneman, R. S. (1984) ‘Platelet- vessel wall interactions: implication of 5-hydroxytryptamine. A review’, Agent Actions 15, 612–626.

    Article  Google Scholar 

  • De Clerck, F. and Xhonneux, B. (1985) ‘Effects of ketanserin, a selective 5-HT2 serotonergic antagonist, in the secondary recruitment of human platelets in vitro’, Agents Actions 17, 515–526.

    Article  Google Scholar 

  • De Clerck, F., Xhonneux, B. and de Chaffoy de Courcelles, D. (1988) ‘Functional expression of the amplification reaction between serotonin and epinephrine on platelets’, J. Cardiovasc. Pharmacol. 11 (Suppl. 1), S1–S5.

    Google Scholar 

  • De Clerck, F., Xhonneux, B., Leysen, J. E. and Janssen, P. A. J. (1984) ‘Evidence for functional 5-HT2 receptor sites on human blood platelets’, Biochem. Pharmacol. 33, 2807–2811.

    Article  PubMed  Google Scholar 

  • De Clerck, F., Xhonneux, B., Leysen, J. E. and Janssen, P. A. J. (1984) ‘The involvement of 5-HT2-receptor sites in the activation of cat platelets’, Thromb. Res. 33, 305–321.

    Google Scholar 

  • De Cree, J., Geukens, H., Leempoels, J. and Verhaegen, H. (1985b) ‘The effects of ketanserin, a 5-HT2-receptor antagonist on the impaired blood cell filtration in patients with acute myocardial infarction’, Clin. Haemorheol. 5, 949–957.

    Google Scholar 

  • De Cree, J., Leempoels, J., Demoen, B., Roels, V. and Verhaegen, H. (1985a) ‘Effect of ketanserin in the hyperreactivity of platelets to 5-hydroxytryptamine in patients with cardiovascular diseases’, J. Cardiovasc. Pharmacol. 7, S26–S28.

    Article  PubMed  Google Scholar 

  • De La Lande, I. S., Cannel, V. A. and Waterson, J. G. (1966) ‘The interaction of serotonin and noradrenaline on the perfused artery’, Br. J. Pharmacol. Chemother. 28, 255–272.

    Google Scholar 

  • DeMey, C. and Vanhoutte, P. M. (1981) ‘Effect of age and spontaneous hypertension on the tachyphylaxis to 5-hydroxytryptamine and angiotensin II in the isolated rat kidney’, Hypertension 3, 718–724.

    Google Scholar 

  • Dormandy, J. A. (1985) ‘HemoTheological effects of serotonin and serotonergic antagonists’, in P. M. Vanhoutte (ed.), Serotonin and the Cardiovascular System, Raven Press, New York, pp. 179–188.

    Google Scholar 

  • Doyle, E. A., Fraser, J. R. E. and Marshall, R. J. (1959) ‘Reactivity of forearm vessels to vasoconstrictor substances in hypertensive and normotensive subjects’, Clin. Sci. 18, 441–454.

    PubMed  CAS  Google Scholar 

  • Engel, G., Gothert, M., Miiller-Schweinitzer, E., Schlicker, E., Sistonen, L. and Stadler, P. A. (1983) ‘Evidence for common pharmacological properties of [3H]5-hydroxytryptamine binding sites, presynaptic 5-hydroxytryptamine autoreceptors in CNS and inhibitory presynaptic 5-hydroxytryptamine receptors on sympathetic nerves’, Naunyn Schmiedebergs Arch. Pharmacol. 324, 116–124.

    Article  CAS  Google Scholar 

  • Flavahan, N. A., Shimokawa, H. and Vanhoutte, P. M. (1989) ‘Pertussis toxin inhibits endothelium-dependent relaxations to certain agonists in porcine coronary arteries’, J. Physiol. 408, 549–560.

    PubMed  CAS  Google Scholar 

  • Forster, C., Whalley, E. T., Mohan, J. and Dutton, J. (1980) ‘Vascular smooth muscle response to fibrinogen degradation products and 5-hydroxytryptamine: Possible role in cerebral vasospasm in man’, Br. J. Clin. Pharmacol. 10, 231–236.

    PubMed  CAS  Google Scholar 

  • Garland, C. J. (1985) ‘Endothelial cells and the electrical and mechanical responses of the rabbit coronary artery to 5-hydroxytryptamine’, J. Pharmacol. Exp. Ther. 233, 158–162.

    PubMed  CAS  Google Scholar 

  • Gershon, M. D. and Tamir, H. (1985) ‘Peripheral sources of serotonin and serotonin-binding proteins’, in P. M. Vanhoutte (ed.), Serotonin and the Cardiovascular System, Raven Press, New York, pp. 15–26.

    Google Scholar 

  • Gillis, C. N. (1985) ‘Peripheral metabolism of serotonin’, in P. M. Vanhoutte (ed.), Serotonin and the Cardiovascular System, Raven Press, New York, pp. 27–36.

    Google Scholar 

  • Glusa, E. and Markwardt, F. (1984) ‘Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine-blocking agents’, Biomed. Biochim. Acta. 43, 215–220.

    PubMed  CAS  Google Scholar 

  • Golino, P., Buja, L. M., Ashton, J. H., Kulkarni, P., Taylor, A. and Willerson, J. T. (1988a) ‘Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries’, Circulation 78, 701–711.

    Article  PubMed  CAS  Google Scholar 

  • Golino, P., Ashton, J. H., Glas-Greenwalt, P., McNatt, J., Buja, L. M. and Willerson, J. T. (1988) ‘Mediation of reocclusion by thromboxane A2 and serotonin after thrombolysis with tissue-type plasminogen activator in a canine preparation of coronary thrombosis’, Circulation 77, 678–684.

    Article  PubMed  CAS  Google Scholar 

  • Haeusler, G. and Finch, L. (1972) ‘Vascular reactivity to 5-hydroxytryptamine and hypertension in the rat’, Naunyn Schmiedebergs Arch. Pharmacol. 272, 101–116.

    Article  CAS  Google Scholar 

  • Heistad, D. D., Armstrong, M. L., Marcus, M. L., Piegors, D. J. and Mark, A. L. (1984) ‘Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys’, Circ. Res. 54, 711–718.

    PubMed  CAS  Google Scholar 

  • Hogan, J. C., Lewis, M. J. and Henderson, A. J. (1988) ‘In vivo EDRF activity influences platelet function’, Br. J. Pharmacol. 94, 1020–1022.

    PubMed  CAS  Google Scholar 

  • Hollenberg, N. K. (1985) ‘Segmental vascular responses to serotonin’, in P. M. Vanhoutte (ed.), Serotonin and the Cardiovascular System, Raven Press, New York, pp. 165–170.

    Google Scholar 

  • Houston, D. S., Shepherd, J. T. and Vanhoutte, P. M. (1985) ‘Adenine nucleotides, serotonin and endothelium-dependent relaxations to platelets’, Am. J. Physiol. 248, H389 - H395.

    PubMed  CAS  Google Scholar 

  • Houston, D. S. and Vanhoutte, P. M. (1986) ‘Serotonin and the vascular system. Role in health and disease, and implications for therapy’, Drugs 31, 149–163.

    Article  PubMed  CAS  Google Scholar 

  • Humphrey, W. R. and Aiken, J. W. (1982) ‘Antithrombotic and hypotensive effects of the serotoni receptor antagonist ketanserin in anesthetized dogs’, Pharmacologist 24, 196.

    Google Scholar 

  • Janssens, W. J. and Van Nueten, J. M. (1986) ‘The direct and amplifying effects of serotonin are increased with age in the isolated perfused kidney of Wistar and spontaneously hypertensive rats’, Naunyn Schmiedebergs Arch. Pharmacol. 334, 327–332.

    Article  CAS  Google Scholar 

  • Kubo, T. and Su, C. (1983) ‘Effects of serotonin and some other neurohumoral agents on adrenergic neurotransmission in spontaneously hypertensive rat vasculature’, Clin. Exp. Hypertens. (A) 5, 1501–1510.

    Google Scholar 

  • Lamping, K. G. and Dole, W.P. (1987) ‘Acute hypertension selectively potentiates constrictor responses of large coronary arteries to serotonin by altering endothelial function in vivo’. Circ. Res. 61, 904–913.

    PubMed  CAS  Google Scholar 

  • Lorenz, R. R. and Vanhoutte, P. M. (1984) ‘Aggregating platelets and adrenergic neurotransmission in isolated canine blood vessels’, Fed. Proc. 43, 430.

    Google Scholar 

  • Lüscher, T. F. (1988) Endothelial vasoactive substances and cardiovascular disease, Karger, Basel.

    Google Scholar 

  • Macdonald, P. S., Read, M. A. and Dusting, G. J. (1988) ‘Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin’, Thromb. Res. 49, 437–449.

    Article  PubMed  CAS  Google Scholar 

  • Marwood, J. F. and Stokes, G. S. (1984) ‘Serotonin (5HT) and its antagonists: Involvement in the cardiovascular system’, Clin. Exp. Pharmacol. Physiol. 11, 439–455.

    Article  PubMed  CAS  Google Scholar 

  • McGrath, M. A. (1977) ‘5-Hydroxytryptamine and neurotransmitter release in canine blood vessels’, Circ. Res. 41, 428–435.

    PubMed  CAS  Google Scholar 

  • McGregor, D. D., Smirk, F. H. (1970) ‘Vascular responses to 5-hydroxytryptamine in genetic and renal hypertensive rats’, Am. J. Physiol. 219, 687–690.

    PubMed  CAS  Google Scholar 

  • Mecca, T. E., Mitchell, J., Bohr, D. F., Webb, R. C. (1985) ‘Effects of serotonin antagonists on blood pressure in mineralocorticoid hypertensive sheep’, J. Cardiovasc. Pharmacol. 7, 660–665.

    Article  PubMed  CAS  Google Scholar 

  • Meyers, J. H., Mecca, T. E., Webb, R. C. (1985) ‘Direct and sensitizing effects of serotonin agonists and antagonists on vascular smooth muscle’, J. Cardiovasc. Pharmacol. 7 (Suppl. 7), S44–S48.

    Article  Google Scholar 

  • Moncada, S., Vane, J. R. (1979) ‘The role of prostacyclin in vascular tissue’, Fed. Proc. 38, 66–71.

    PubMed  CAS  Google Scholar 

  • Mullane, K. M., Bradley, G. and Moncada, S. (1982) ‘The interactions of platelet-derived mediators on isolated canine coronary arteries’, Eur. J. Pharmacol. 84, 115–118.

    Article  PubMed  CAS  Google Scholar 

  • Nevelsteen, A., De Clerck, F., Loots, W., De Gryse, A. (1984) ‘Restoration of post-thrombotic peripheral collateral Circulation in the cat by ketanserin, a selective 5-HT2 receptor antagonist’, Arch. Int. Pharmacodyn. Ther. 270, 268–274.

    PubMed  CAS  Google Scholar 

  • Paiva, M. Q., Caramona, M., Osswald, W. (1984) ‘Intraand extraneuronal metabolism of 5-hydroxytryptamine in the isolated saphenous vein of the dog’, Naunyn Schmiedebergs Arch. Pharmacol. 325, 62–68.

    Article  CAS  Google Scholar 

  • Rapport, M. M., Green, A. A., Page, I. H. (1948) ‘Serum vasoconstrictor (serotonin). IV. Isolation and characterization’, J. Biol. Chem. 176, 1243.

    PubMed  CAS  Google Scholar 

  • Radomski, M. W., Palmer, R. M. J., Moncada, S. (1987) ‘Comparative pharmacology of endothelium-derived relaxing factor, nitric oxide and prostacyclin in platelets’, Br. J. Pharmacol. 92, 181–187.

    PubMed  CAS  Google Scholar 

  • Radomski, M. W., Palmer, R. M. J., Moncada, S. (1987) ‘Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium’, The Lancet 2, 1057–1058.

    Article  CAS  Google Scholar 

  • Ross, R. (1987) ‘Growth factors in the pathogenesis of atherosclerosis’, Acta Med. Scand. 715, 33–38.

    CAS  Google Scholar 

  • Shimokawa, H., Aarhus, L. L., Vanhoutte, P. M. (1987) ‘Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin’, Circ. Res. 61, 256–270.

    PubMed  CAS  Google Scholar 

  • Shimokawa, H., Aarhus, L. L., Vanhoutte, P. M. (1987) ‘Porcine coronary arteries with regenerated endothelium have a reduced endothelium-dependent responsiveness to aggregating platelets and serotonin’, Circ. Res. 61, 256–270.

    PubMed  CAS  Google Scholar 

  • Sneddon, J. M., Vane, J. R. (1988) ‘Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells’, Proc. Natl. Acad. Sci. 85, 2800–2804.

    Article  PubMed  CAS  Google Scholar 

  • Stoltz, J. F. (1985) ‘Uptake and storage of serotonin by platelets’, in P. M. Vanhoutte (ed.), Serotonin and the Cardiovascular System, Raven Press, New York, pp. 37–42.

    Google Scholar 

  • Toda, N., Bian, K., Inoue, S. (1987) ‘Age-related changes in the response to vasoconstrictor and dilator agents in isolated beagle coronary arteries’, Naunyn Schmiedebergs Arch. Pharmacol. 336, 359–364.

    Article  CAS  Google Scholar 

  • Toda, N., Hayashi, S. (1979) ‘Age-dependent alteration in the response of silated rabbit basilar arteries to vasoactive agents’, J. Pharmacol. Exp. Ther. 211, 716–721.

    PubMed  CAS  Google Scholar 

  • Vanhoutte, P. M. (1985) ‘Peripheral serotonergic receptors and hypertension’, in P. M. Vanhoutte (ed.), Serotonin and the Cardiovascular System, Raven Press, New York, pp. 123–133.

    Google Scholar 

  • Vanhoutte, P. M., Houston, D. S. (1985) ‘Platelets, endothelium, and vasospasm’, Circulation 72, 728–734.

    Article  PubMed  CAS  Google Scholar 

  • Vanhoutte, P. M., Verbeuren, T. J. Webb, R. C. (1981) ‘Local modulation of the adrenergic neuroeffector interaction in the blood vessel wall’, Physiol. Rev. 61, 151–247.

    PubMed  CAS  Google Scholar 

  • Van Nueten, J. M. (1982) ‘Serotonergic amplification mechanisms in vascular tissues’, in F. De Clerck and P. M. Vanhoutte (eds.), 5-hydroxytryptamine in Peripheral Reactions, Raven Press, New York, pp. 77–82.

    Google Scholar 

  • Van Nueten, J. M., Janssen, P. A. J., De Ridder, W., Vanhoutte, P. M. (1982) ‘Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit: Effect of ketanserin (R 41 468)’, Eur. J. Pharmacol. 77, 281–287.

    Article  PubMed  Google Scholar 

  • Van Nueten, J. M., Janssen, P. A. J., Van Beek, J., Xhonneux, R., Verbeuren, T. J., Vanhoutte, P. M. (1981) ‘Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors’, J. Pharmacol. Exp. Ther. 218, 217–230.

    PubMed  Google Scholar 

  • Van Nueten, J. M., Janssens, W. J., Vanhoutte, P. M. (1985) ‘Serotonin and vascular smooth muscle’, in P. M. Vanhoutte (ed.), Serotonin and the Cardiovascular System, Raven Press, New York, pp. 95–104.

    Google Scholar 

  • Van Nueten, J. M., Leysen, J. E. De Clerck, F., Vanhoutte, P. M. (1984) ‘Serotonergic receptor subtypes and vascular reactivity’, J. Cardiovasc. Pharmacol. 6, 5564–5574.

    Google Scholar 

  • Verbeuren, T. J., Jordaens, F. H., Herman, A. G. (1983) ‘Accumulation and release of [3H]–5-hydroxytryptamine in saphenous veins and cerebral arteries of the dog’, J. Pharmacol. Exp. Ther. 226, 579–588.

    PubMed  CAS  Google Scholar 

  • Verbeuren, T. J., Jordaens, F. H., Zonnekeyn, L. L., Van Hove, C. E., Coene, M. C., Herman, A. G. (1986) ‘Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contractions and relaxations in isolated arteries of control and hypercholesterolemic rabbits’, Circ. Res. 58, 552–564.

    PubMed  CAS  Google Scholar 

  • Verheyen, A., Vlaminckx, E., Lauwers, F., Van den Broeck, C., Wouters, L. (1984) ‘Serotonin-induced blood flow changes in the rat hindlegs after unilateral ligation of the femoral artery: inhibition by the S2-receptor antagonist ketanserin’, Arch. Int. Pharmacodyn. Ther. 270, 280–298.

    PubMed  CAS  Google Scholar 

  • Webb, R. C., Vanhoutte, P. M. (1985) ‘Responsiveness of the hypertensive blood vessel wall to serotonergic stimuli’, in P. M. Vanhoutte (ed.), Serotonin and the Cardiovascular System, Raven Press, New York, pp. 113–121.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1990 Kluwer Academic Publishers

About this chapter

Cite this chapter

Vanhoutte, P.M., Van Nueten, J.M., Janssens, W.J. (1990). The Role of the Endothelium in the Cardiovascular Response to Serotonin. In: Paoletti, R., Vanhoutte, P.M., Brunello, N., Maggi, F.M. (eds) Serotonin. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-1912-9_12

Download citation

  • DOI: https://doi.org/10.1007/978-94-009-1912-9_12

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-7353-0

  • Online ISBN: 978-94-009-1912-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics